NCT06407024 Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy
| NCT ID | NCT06407024 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cleveland Clinic |
| Condition | Adrenalectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2024-05-22 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2024-05-22 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to compare Laparoscopic vs Robotic lateral transabdominal adrenalectomy, these procedures are both standard of care. The study team would like to compare both patient outcomes and surgeon efficiency and perspectives among both procedures. The information from this study will help improve patient care, patient outcomes and maximize the appropriate utilization of resources in adrenal surgery.
Eligibility Criteria
Inclusion Criteria: 1. Men and women between ages 18 and 75 2. Diagnosis of an adrenal tumor/pathology planned for a minimally invasive adrenalectomy at the department of endocrine surgery at the Cleveland Clinic. Exclusion Criteria: 1. Requirement for an open adrenalectomy based on imaging studies suggesting an aggressive cancer. 2. The presence of extensive surgical history precluding a minimally invasive approach to be undertaken. 3. Patients planned for a partial, rather than a complete adrenalectomy, as the former is a much easier procedure. 4. Patients planned for a posterior adrenalectomy (these would be patients with an extensive surgical history with significant intra-abdominal adhesions and those requiring bilateral adrenalectomy). 5. Mental incapacity or language barrier 6. Any condition, unwillingness, or inability, not covered by any of the other exclusion criteria, which, in the study clinician's opinion, might jeopardize the subject's safety or compliance with the protocol
Contact & Investigator
Eren Berber, MD
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT06407024 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Adrenalectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06407024 currently recruiting?
Yes, NCT06407024 is actively recruiting participants. Contact the research team at jenkink@ccf.org for enrollment information.
Where is the NCT06407024 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT06407024 clinical trial?
NCT06407024 is sponsored by The Cleveland Clinic. The principal investigator is Eren Berber, MD at The Cleveland Clinic. The trial plans to enroll 54 participants.